ArticlePharmaceuticals (Basel, Switzerland)2023

P2Y12 Inhibitor Monotherapy versus Conventional Dual Antiplatelet Therapy in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Meta-Analysis.

Wen-Han Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.